Evidence map›Paper›PMID 34684054›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Effects of Antithrombotic Agents on Ophthalmological Outcomes, Cardiovascular Risk, and Mortality in Hypertensive Patients with Retinal Vein Occlusion: An Exploratory Retrospective Study.

Federica Bertoli, Bruno Bais, Daniele De Silvestri, Barbara Mariotti, Daniele Veritti, Alessandro Cavarape, Cristiana Catena, Paolo Lanzetta, Leonardo Alberto Sechi, GianLuca Colussi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Federica BertoliDivision of Ophthalmology, Monfalcone-Gorizia Hospital (ASUGI), 34074 Monfalcone, Italy.ORCID 0000-0001-9526-9472
Bruno BaisThrombosis Prevention Unit, Division of Internal Medicine, Academic Hospital of Udine (ASUFC), 33100 Udine, Italy.
Daniele De SilvestriThrombosis Prevention Unit, Division of Internal Medicine, Academic Hospital of Udine (ASUFC), 33100 Udine, Italy.
Barbara MariottiThrombosis Prevention Unit, Division of Internal Medicine, Academic Hospital of Udine (ASUFC), 33100 Udine, Italy.
Daniele VerittiDepartment of Medicine-Ophthalmology, University of Udine, 33100 Udine, Italy.
Alessandro CavarapeHypertension Unit, Department of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0003-2726-5714
Cristiana CatenaHypertension Unit, Department of Medicine, University of Udine, 33100 Udine, Italy.
Paolo LanzettaDepartment of Medicine-Ophthalmology, University of Udine, 33100 Udine, Italy.ORCID 0000-0003-3746-141X
Leonardo Alberto SechiHypertension Unit, Department of Medicine, University of Udine, 33100 Udine, Italy.
GianLuca ColussiHypertension Unit, Department of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0003-1673-540X
University of Udine · ITOspedale di Monfalcone · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesRetinal Vein OcclusionAgedAged, 80 and overFibrinolytic AgentsFollow-Up StudiesHeart Disease Risk FactorsHumansIntravitreal InjectionsMaleMiddle AgedProspective StudiesRetrospective StudiesRisk FactorsTomography, Optical CoherenceTreatment OutcomeFibrinolytic Agentsanticoagulantsantiplatelet drugscardiovascular diseasesurvival analysisvisual acuity

Identifiers

PMID34684054
PMCPMC8537937
OpenAlexW3202118904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.